Human α1-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain
Biomolecules · 23.07.2026 · 16 (8) · 1074
DOI: 10.3390/biom16081074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 23.07.2026. Verfasst von Alaina L Waters und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gaine…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, Neuralgia, Inflammation, Nociceptors. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florida.
Abstract (Originalsprache)
Chronic pain affects hundreds of millions of people and remains poorly managed, as the most effective drugs, including opioids, carry side effects that limit long-term use. Because inflammation drives both the initiation and maintenance of chronic pain, anti-inflammatory mechanisms are an attractive analgesic target. We investigated human alpha-1 antitrypsin (hAAT), a serine proteinase inhibitor with potent anti-inflammatory activity and established protection across disease models, as a candidate analgesic, using Aralast NP®, a clinical-grade, already-approved formulation that makes findings directly translatable. Using calcium imaging and patch-clamp electrophysiology in mouse dorsal root ganglion (DRG) neurons, we found that hAAT reduced activation of low-voltage-activated Ca2+ channels and dampened intrinsic excitability. Veratridine-evoked Ca2+ responses, a sodium-channel-dependent readout of nociceptor activity, were suppressed by hAAT to a degree comparable to the selective sodium channel inhibitors ProTx-II (NaV1.7) and VX-548 (NaV1.8), driven by loss of the nociceptor-associated response profiles. In vivo, hAAT decreased pain sensitivity and pain-associated behaviors in both inflammatory and neuropathic models. Together, these findings reveal a mechanism by which hAAT suppresses nociceptor activity and position Aralast NP® as a safe, effective candidate for treating chronic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
- Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
ORCID-Profile: Alaina L Waters, Santiago Loya-López, Erick J Rodriguez-Palma, Shainnel O Eans, Ryosuke Shinouchi, Jay P McLaughlin, Sihong Song, Rajesh Khanna
Förderung
- University of Florida
Zitieren
APA
Waters, A. L., Loya-López, S., Rodriguez-Palma, E. J., Eans, S. O., Shinouchi, R., Stokes, J., McLaughlin, J. P., Song, S., & Khanna, R. (2026). Human α1-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain. Biomolecules, 16(8), 1074. https://doi.org/10.3390/biom16081074
Vancouver
Waters AL, Loya-López S, Rodriguez-Palma EJ, Eans SO, Shinouchi R, Stokes J, et al. Human α1-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain. Biomolecules. 2026;16(8):1074. doi:10.3390/biom16081074
BibTeX
@article{Waters2026,
author = {Waters, Alaina L and Loya-López, Santiago and Rodriguez-Palma, Erick J and Eans, Shainnel O and Shinouchi, Ryosuke and Stokes, Jordan and McLaughlin, Jay P and Song, Sihong and Khanna, Rajesh},
title = {Human α1-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1074},
doi = {10.3390/biom16081074}
}
EUVIMED